Cargando…
The impact of cannabinoids on inflammasome signaling in HIV-1 infection
Human immunodeficiency virus type 1 (HIV-1) is a chronic disease that afflicts over 38 million people worldwide without a known cure. The advent of effective antiretroviral therapies (ART) has significantly decreased the morbidity and mortality associated with HIV-1 infection in people living with H...
Autores principales: | Min, Alice K., Keane, Aislinn M., Weinstein, Matthew Paltiel, Swartz, Talia H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070009/ https://www.ncbi.nlm.nih.gov/pubmed/37027347 http://dx.doi.org/10.1515/nipt-2023-0002 |
Ejemplares similares
-
NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease
por: Mullis, Caroline, et al.
Publicado: (2020) -
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
por: Suryavanshi, Santosh V., et al.
Publicado: (2021) -
Targeting the NLRP3 Inflammasome in Severe COVID-19
por: Freeman, Tracey L., et al.
Publicado: (2020) -
Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation
por: Swartz, Talia H., et al.
Publicado: (2015) -
Inflammasome signaling proteins as biomarkers of COVID-19
por: Hadad, Roey, et al.
Publicado: (2023)